Preventive effect of pancreatic stent placement for post-ERCP pancreatitis and hyperamylasemia in high-risk patients
Yao Ru
Abstract
Yao Ru
Abstract
[Objective]To investigate the preventive effect of pancreatic stent placement on post-ERCP pancreatitis(PEP) and hyperamylasemia.[Methods]We retrospectively analyzed the 123 patients with high-risk PEP between March 2006 and June 2012.The patients were divided into stent placement group(n=53) and non-stent placement group(n=70).PEP and hyperamylasemia were diagnosed according to Cotton standard.Preoperative and 6-hours-postoperative serum amylase levels were obtained.Occurrence of PEP and hyperamylasemia and prognosis were assessed.The high-risk factors influencing PEP were analyzed.[Results]Serum amylase levels before ERCP of both groups were normal.The serum amylase level of stent placement 6 hours after surgery was [(357.7±198.3)U/L],which was lower than that of non-stent placement group [(484.7±376.9)U/ L](P0.05).The incidence of PEP of stents placement group(24.5%) was lower than that of control group(55.7%)(P0.05).Post-ERCP hyperamylasemia incidence of stents placement(40.2%)was higher than that of the control group(20.0%)(P0.05).[Conclusion]Pancreatic stents placement after ERCP can effectively reduce the incidence of PEP and reduce amylase levels of patients with hyperamylasemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]To investigate the preventive effect of pancreatic stent placement on post-ERCP pancreatitis(PEP) and hyperamylasemia.[Methods]We retrospectively analyzed the 123 patients with high-risk PEP between March 2006 and June 2012.The patients were divided into stent placement group(n=53) and non-stent placement group(n=70).PEP and hyperamylasemia were diagnosed according to Cotton standard.Preoperative and 6-hours-postoperative serum amylase levels were obtained.Occurrence of PEP and hyperamylasemia and prognosis were assessed.The high-risk factors influencing PEP were analyzed.[Results]Serum amylase levels before ERCP of both groups were normal.The serum amylase level of stent placement 6 hours after surgery was [(357.7±198.3)U/L],which was lower than that of non-stent placement group [(484.7±376.9)U/ L](P0.05).The incidence of PEP of stents placement group(24.5%) was lower than that of control group(55.7%)(P0.05).Post-ERCP hyperamylasemia incidence of stents placement(40.2%)was higher than that of the control group(20.0%)(P0.05).[Conclusion]Pancreatic stents placement after ERCP can effectively reduce the incidence of PEP and reduce amylase levels of patients with hyperamylasemia.
Key concepts: Hyperamylasemia, Medicine, Incidence (geometry), Pancreatitis, Stent, Gastroenterology, Internal medicine, Amylase